Janine Kirby

11.2k citations

79 papers · 5.2k indexed · 2 hit papers · h-index 37

Neurology top 0.1%
Genetics top 0.2%
Molecular Biology top 5%
Neurology top 0.5%
Cellular and Molecular Neuroscience top 2%

Co-authors: Pamela J. Shaw Paul R. Heath Laura Ferraiuolo Johnathan Cooper‐Knock Paul G. Ince J. Robin Highley Andrew J. Grierson Adrian Higginbottom
Topics: Amyotrophic Lateral Sclerosis Research (62 papers)Neurogenetic and Muscular Disorders Research (39 papers)Neurological diseases and metabolism (20 papers)
Cited by: Neurology Genetics
Journals: The Lancet Journal of Biological Chemistry Journal of Neuroscience
Partner nations: United Kingdom United States Germany

In The Last Decade

Janine Kirby

78 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations

2007 761 citations Ian R. Mackenzie, Eileen H. Bigio et al. Annals of Neurology profile →
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

2011 465 citations Laura Ferraiuolo, Janine Kirby et al. profile →

Peers

Countries citing papers authored by Janine Kirby

Since Specialization

Citations

This map shows the geographic impact of Janine Kirby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janine Kirby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janine Kirby more than expected).

Fields of papers citing papers by Janine Kirby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janine Kirby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janine Kirby. The network helps show where Janine Kirby may publish in the future.

Co-authorship network of co-authors of Janine Kirby

This figure shows the co-authorship network connecting the top 25 collaborators of Janine Kirby. A scholar is included among the top collaborators of Janine Kirby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janine Kirby. Janine Kirby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular pathogenesis of ameloblastoma 2024 ·Journal of Oral Pathology and Medicine ·(unknown),Janine Kirby,Keith D. Hunter	5
2	A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders 2024 ·Molecular Therapy ·(unknown),(unknown),(unknown),Christopher P Webster,Eli Harriss,Fraser McBlane,Corinne Betts,Jorge Schettini,(unknown),John E. Mindur,(unknown),Pamela J. Shaw,Janine Kirby,Mimoun Azzouz,Laurent Servais	24
3	What Next After MBSR/MBCT? An Open Trial of an 8-Week Follow-on Program Exploring Mindfulness of Feeling Tone (vedanā) 2022 ·Mindfulness ·Julianne Williams,Ruth A. Baer,(unknown),Rebecca Crane,Chris Cullen,Katherine De Wilde,Melanie Fennell,(unknown),Janine Kirby,S. Helen,Emma Medlicott,Barbara Gerber,(unknown),(unknown),John W. Peacock,(unknown),(unknown),Lucy Radley,(unknown),Laura Taylor	7
4	Value of systematic genetic screening of patients with amyotrophic lateral sclerosis 2021 ·Journal of Neurology Neurosurgery & Psychiatry ·Stephanie Shepheard,Matthew Parker,Johnathan Cooper‐Knock,Nick Verber,Lee Tuddenham,Paul R. Heath,Nick Beauchamp,Elsie Place,Elizabeth Sollars,Martin R. Turner,Andrea Malaspina,Pietro Fratta,Channa Hewamadduma,Thomas M. Jenkins,Christopher McDermott,Dennis Wang,Janine Kirby,Pamela J. Shaw	70
5	Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia 2018 ·Neurobiology of Aging ·Soragia Athina Gkazi,Claire Troakes,Simon Topp,Jack W. Miller,Caroline Vance,Jemeen Sreedharan,Ammar Al‐Chalabi,Janine Kirby,Pamela J. Shaw,Safa Al‐Sarraj,Andrew King,Bradley Smith,Christopher E. Shaw	15
6	IMMUNO-MODULATION IN AMYOTROPHIC LATERAL SCLEROSIS - A PHASE II STUDY OF SAFETY AND ACTIVITY OF LOW DOSE INTERLEUKIN-2 (IMODALS study) (S3.006) 2017 ·Neurology ·Gilbert Bensimon,William Camu,Christine Payan,Timothy Tree,Jean‐Luc Veyrune,Andrea Malaspina,Cecília Garlanda,Massimo Locati,(unknown),Raúl Juntas‐Morales,Nicolas Pageot,John De Vos,Janine Kirby,Ammar Al‐Chalabi,Peter Leigh	1
7	Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS) 2017 ·Neurobiology of Aging ·Rachel Waller,Gerald Goodall,Marta Milo,Johnathan Cooper‐Knock,Marc Da Costa,Esther Hobson,Mbombe Kazoka,(unknown),Paul R. Heath,Pamela J. Shaw,Janine Kirby	111
8	The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients 2015 ·Neurobiology of Aging ·Chun Hao Wong,Simon Topp,Soragia Athina Gkazi,Claire Troakes,Jack W. Miller,Martina de Majo,Janine Kirby,Pamela J. Shaw,Karen Morrison,Jacqueline de Belleroche,Caroline Vance,Ammar Al‐Chalabi,Safa Al‐Sarraj,Christopher E. Shaw,Bradley Smith	14
9	C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis 2015 ·PLoS ONE ·Johnathan Cooper‐Knock,Joanna J. Bury,Paul R. Heath,Matthew Wyles,Adrian Higginbottom,Catherine Gelsthorpe,J. Robin Highley,Guillaume M. Hautbergue,Magnus Rattray,Janine Kirby,Pamela J. Shaw	77
10	Stratified gene expression analysis identifies major amyotrophic lateral sclerosis genes 2015 ·Neurobiology of Aging ·Ashley Jones,Claire Troakes,Andrew King,Vibhu Sahni,Simone de Jong,Koen Bossers,Efterpi Papouli,Muddassar M. Mirza,Safa Al‐Sarraj,Christopher E. Shaw,Pamela J. Shaw,Janine Kirby,Jan H. Veldink,Jeffrey D. Macklis,John Powell,Ammar Al‐Chalabi	21
11	Comparison of Blood RNA Extraction Methods Used for Gene Expression Profiling in Amyotrophic Lateral Sclerosis 2014 ·PLoS ONE ·Nadhim Bayatti,Johnathan Cooper‐Knock,Joanna J. Bury,Matthew Wyles,Paul R. Heath,Janine Kirby,Pamela J. Shaw	22
12	Neurodegeneration caused by intronic expansions of C9ORF72 is a clinically heterogeneous but pathologically distinct disease 2013 ·The Lancet ·Johnathan Cooper‐Knock,J. Robin Highley,Judith Hartley,Antonio Milano,Stephen Sawcer,(unknown),(unknown),Gavin Charlesworth,Nicholas Wood,Oliver Bandmann,Christopher McDermott,Janine Kirby,Paul G. Ince,Pamela J. Shaw	1
13	S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis 2013 ·Free Radical Biology and Medicine ·Richard J. Mead,Adrian Higginbottom,Scott P. Allen,Janine Kirby,Ellen Bennett,Siân C. Barber,Paul R. Heath,Antonio Coluccia,Neelam Patel,Iain Gardner,Andrea Brancale,Andrew J. Grierson,Pamela J. Shaw	55
14	ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN 2013 ·Human Molecular Genetics ·Ewout J. N. Groen,Katsumi Fumoto,Anna M. Blokhuis,Joo-Yeon Engelen-Lee,Yeping Zhou,Dianne M.A. van den Heuvel,Max Koppers,Femke van Diggelen,(unknown),Jeroen Demmers,Janine Kirby,Pamela J. Shaw,Eleonora Aronica,Wim G.M. Spliet,Jan H. Veldink,Leonard H. van den Berg,R. Jeroen Pasterkamp	113
15	Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity 2012 ·Acta Neuropathologica ·Alice Brockington,Ke Ning,Paul R. Heath,Elizabeth Wood,Janine Kirby,Nicolò Fusi,Neil D. Lawrence,Stephen B. Wharton,Paul G. Ince,Pamela J. Shaw	119
16	Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS) 2010 ·PLoS ONE ·Laura Cox,Laura Ferraiuolo,Gerald Goodall,Paul R. Heath,Adrian Higginbottom,Heather Mortiboys,Hannah Hollinger,Judith Hartley,Alice Brockington,Christine Burness,Karen Morrison,Stephen B. Wharton,Andrew J. Grierson,Paul G. Ince,Janine Kirby,Pamela J. Shaw	198
17	Transcriptional response of the neuromuscular system to exercise training and potential implications for ALS 2009 ·Journal of Neurochemistry ·Laura Ferraiuolo,Joseph de Bono,Paul R. Heath,Hazel M. Holden,Paul R. Kasher,Keith M. Channon,Janine Kirby,Pamela J. Shaw	34
18	New pedigrees and novel mutation expand the phenotype of REEP1-associated hereditary spastic paraplegia (HSP) 2008 ·Neurogenetics ·Channa Hewamadduma,Christopher McDermott,Janine Kirby,Andrew J. Grierson,(unknown),Ann Dalton,(unknown),Pamela J. Shaw	35
19	Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsbreakdown → 2007 ·Annals of Neurology ·Ian R. Mackenzie,Eileen H. Bigio,Paul G. Ince,Felix Geser,Manuela Neumann,Nigel J. Cairns,Linda K. Kwong,Mark S. Forman,John Ravits,Heather Stewart,Andrew Eisen,(unknown),Hans A. Kretzschmar,Camelia Maria Monoranu,J. Robin Highley,Janine Kirby,Teepu Siddique,Pamela J. Shaw,(unknown),John Q. Trojanowski	761
20	Origins of some dynorphin containing pathways in the substantia nigra ventral tegmental area of the rat 1984 ·The Society for Neuroscience Abstracts ·James H. Fallon,(unknown),Janine Kirby,F.M. Leslie,Ric I. Cone	1

About Janine Kirby

Janine Kirby is a scholar working on Neurology, Genetics and Neurology, having authored 79 papers that have together received 5.2k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (62 papers), Neurogenetic and Muscular Disorders Research (39 papers) and Neurological diseases and metabolism (20 papers). The work is most often cited by research in Neurology (3.8k citations), Genetics (2.3k citations) and Neurology (1.0k citations). Janine Kirby has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Pamela J. Shaw, Paul R. Heath, Laura Ferraiuolo, Johnathan Cooper‐Knock, Paul G. Ince, J. Robin Highley, Andrew J. Grierson, Adrian Higginbottom, Stephen B. Wharton and Michael Sendtner. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact